Article

(2022) Cellular and Molecular Aspects of Managing Familial Hypercholesterole-mia: Recent and Emerging Therapeutic Approaches. Endocrine, Metabolic and Immune Disorders - Drug Targets. pp. 1018-1028. ISSN 18715303 (ISSN)

(2020) Limb-girdle Muscular Dystrophy and Therapy: Insights into Cell and Gene-based Approaches. Current Gene Therapy. pp. 386-394. ISSN 1566-5232

(2020) Molecular Pathways, Screening and Follow-up of Colorectal Carcinogenesis: An Overview. Current Cancer Therapy Reviews. pp. 88-96. ISSN 1573-3947

(2020) The atherogenic role of immune cells in familial hypercholesterolemia. Iubmb Life. pp. 782-789. ISSN 1521-6543

(2019) Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives. Molecular Neurobiology. pp. 4799-4811. ISSN 0893-7648

(2019) Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies. Journal of Cellular Physiology. pp. 19307-19319. ISSN 0021-9541

(2019) Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A review. Journal of Cellular Biochemistry. pp. 8891-8898. ISSN 0730-2312

(2019) Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer. Current Protein & Peptide Science. pp. 926-934. ISSN 1389-2037